ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Pharma raises its bet on biotech"
Episode Synopsis
In the past month pharmaceutical companies have spent almost $100bn acquiring biotech companies. The FT's Sarah Neville explains why big pharma is raising its bet on the drug pipelines owned by biotechs, and why analysts expect more consolidation in 2019. from Sarah at FT.com. Hosted on Acast. See acast.com/privacy for more information.
More episodes of the podcast Behind the Money
Martin Wolf on the economy in 2026
07/01/2026
As digital scams surge, who’s responsible?
31/12/2025
The quiet success of Fidelity Investments
17/12/2025
In God we trust